Iotrolan

Generic Name: iotrolan

Over-the-Counter (OTC)

Manufactured by BAYER HLTHCARE. Dosage form: INJECTABLE. Route: INTRATHECAL. Active ingredients: IOTROLAN (40.6%). Application: NDA019580.

Overview

Manufactured by BAYER HLTHCARE. Dosage form: INJECTABLE. Route: INTRATHECAL. Active ingredients: IOTROLAN (40.6%). Application: NDA019580.

Dosage

Available as injectable for intrathecal use.

Related Medications

Iodoxamate Meglumine

iodoxamate meglumine

Manufactured by BRACCO. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IODOXAMATE MEGLUMINE (40.3%). Application: NDA018076.

Tacrine Hydrochloride

tacrine hydrochloride

Manufactured by SHIONOGI INC. Dosage form: CAPSULE. Route: ORAL. Active ingredients: TACRINE HYDROCHLORIDE (EQ 20MG BASE). Application: NDA020070.

11 DESCRIPTION Mosunetuzumab-axgb is a bispecific CD20-directed CD3 T-cell engager. It is a humanized monoclonal anti-CD20xCD3 T-cell-dependent bispecific antibody of the immunoglobulin G1 (IgG1) isotype. Mosunetuzumab-axgb is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology. The approximate molecular weight is 146 kDa. LUNSUMIO VELO (mosunetuzumab-axgb) injection is a sterile, preservative-free, colorless to slightly brownish-yellow solution for subcutaneous use.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.